Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00656812Phase 2Completed
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma
Lymphoma of Mucosa-Associated Lymphoid Tissue
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

AKH Wien / Universitaetsklinik fuer Innere Medizin I

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Antonio Salar, MD

Hospital del Mar

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Emilio Montserrat, MD

Clinic Hospital Universitari, Hematology. Barcelona

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Werner Dolak, MD

Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterologie and Hepatologie

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Eulogio Conde, MD

Marqués de Valdecilla Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Giovanni Martinelli, MD

Hemato-oncology. European Oncology Institute. Milan

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

José Javier Sánchez-Blanco, MD

Morales Meseguer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Reyes Arranz, MD

La Princesa Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Maurizio Martelli, MD

Hematology. Università La Sapienza. Roma

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Joan Bargay, MD

Son Llátzer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Emanuele Zucca, MD

International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland. Bellinzona

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00656812Phase 2PrincipalInvestigator

Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma

Lymphoma of Mucosa-Associated Lymphoid Tissue
Completed

All 1 trials loaded